Cited by 287Micro and Nano RoboticsNanoplatforms for cancer theranosticsNanoparticle-Based Drug Delivery

Targeting 3D Bladder Cancer Spheroids with Urease-Powered Nanomotors

Hortelão, Ana C., Carrascosa, Rafael, Murillo-Cremaes, Nerea, Patiño, Tania, Sánchez, Samuel·2019·ACS Nano

Abstract

Cancer is one of the main causes of death around the world, lacking efficient clinical treatments that generally present severe side effects. In recent years, various nanosystems have been explored to specifically target tumor tissues, enhancing the efficacy of cancer treatment and minimizing the side effects. In particular, bladder cancer is the ninth most common cancer worldwide and presents a high survival rate but serious recurrence levels, demanding an improvement in the existent therapies. Here, we present urease-powered nanomotors based on mesoporous silica nanoparticles that contain both polyethylene glycol and anti-FGFR3 antibody on their outer surface to target bladder cancer cells in the form of 3D spheroids. The autonomous motion is promoted by urea, which acts as fuel and is inherently present at high concentrations in the bladder. Antibody-modified nanomotors were able to swim in both simulated and real urine, showing a substrate-dependent enhanced diffusion. The internalization efficiency of the antibody-modified nanomotors into the spheroids in the presence of urea was significantly higher compared with antibody-modified passive particles or bare nanomotors. Furthermore, targeted nanomotors resulted in a higher suppression of spheroid proliferation compared with bare nanomotors, which could arise from the local ammonia production and the therapeutic effect of anti-FGFR3. These results hold significant potential for the development of improved targeted cancer therapy and diagnostics using biocompatible nanomotors.

Integrity signals

Registry

Crossref · 10.1021/acsnano.8b06610

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anti-FGFR3 coupled with PEG-modified mesoporous silica nanoparticles showed higher internalization efficiency for bladder cancer multicellular spheroids and induced stronger cytotoxicity.

    “For example, Hortelao et al. used anti-FGFR3 coupled with PEG-modified mesoporous silica nanoparticles to show higher internalization efficiency for bladder cancer multicellular spheroids and induce stronger cytotoxicity.206”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [206]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hortelão, A. C., Carrascosa, R., Murillo-Cremaes, N., Patiño, T., & Sánchez, S.
Affiliations
  • Barcelona Institute of Science and Technology (ES)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
Corresponding author
  • Patiño, Tania
  • Sánchez, Samuel
Venue
ACS Nano
Published
2018-12-27
Volume
13
Issue
1
Pages
429-439
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W2908190879
Cited by
287
References
66
Citations by year
2026: 24 · 2025: 35 · 2024: 51 · 2023: 32 · 2022: 43 · 2021: 42 · 2020: 48 · 2019: 12
FWCI
13.77
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Nano (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fundaci?n BBVA
  • Secretar?a de Estado de Investigaci?n, Desarrollo e Innovaci?n (CTQ2015-68879-R, CTQ2015-72471-EXP)
  • Generalitat de Catalunya
Topics
  • Physical Sciences › Physics and Astronomy › Condensed Matter Physics › Micro and Nano Robotics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
bladder cancer, tumor spheroids, mesoporous silica nanoparticles, polyethylene glycol coating, urea fuel, targeted drug delivery, ammonia synthesis, FGFR3 inhibition
MeSH terms
Antibodies, Urinary Bladder Neoplasms, Cells, Cultured, Humans, Motion, Polyethylene Glycols, Silicon Dioxide, Tumor Cells, Cultured, Urea, Urease, Spheroids, Cellular, Receptor, Fibroblast Growth Factor, Type 3, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review